Prevention of Recurrent Preterm Delivery by a Natural Progesterone Agent

To examine the preterm delivery rate of a preterm delivery high risk group of pregnant women, using once daily natural progesterone agent...

Date First Received: May 23, 2006

Last Updated: June 26, 2008

Verified by: The Baruch Padeh Medical Center, Poriya, June 2007

Clinical Trial Phase: N/A | Start Date: 

Overall Status: Withdrawn

Brief Summary

Condition Keyword(s):

Intervention(s):

To examine the preterm delivery rate of a preterm delivery high risk group of pregnant women, using once daily natural progesterone agent.

Study Type: Interventional

Study Design: Randomized, Open Label, Uncontrolled, Parallel Assignment, Efficacy Study

Intervention(s) in this Clinical Trial

  • Drug: Crinone Gel 8%

Criteria for Participation in this Clinical Trial

Inclusion Criteria:

  • Pregnancy 24 weeks' gestation Preterm labor in previous pregnancies
    • -

    Exclusion Criteria:

    • No medications for PTL or any kind of progesterone.
    • Cervical suture
    • Multiple pregnancy

Gender Eligibility for this Clinical Trial: Female

Minimum Age for this Clinical Trial: N/A

Maximum Age for this Clinical Trial: N/A

Are Healthy Volunteers Accepted for this Clinical Trial?: No

Clinical Trial Sponsor Information

Lead Sponsor: The Baruch Padeh Medical Center, Poriya

Overall Clinical Trial Officials and Contacts

Yuri Perlitz, MD Study Chair The Baruch Padeh Medical Center, Poriya  

Additional Information

Information obtained from ClinicalTrials.gov on October 06, 2008

Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00329316

Study ID Number: PTL Progesterone Perlitz.CTIL

ClinicalTrials.gov Identifier: NCT00329316

Health Authority: Israel: Israeli Health Ministry Pharmaceutical Administration

Clinical Trials Authorship and Review

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.